Pemetrexed Mylan Pharma

Medicinal product

(Invented) name

Pemetrexed Mylan Pharma

Active substance (s)

Pemetreksedas

Strength

500 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01BA04, Pemetrexed

Marketing authorisation holder

Mylan S.A.S., Prancūzija

Date of authorisation

2016-05-27

Date of renewal

Documents

3922_1_3 Pakuotės lapelis 201112.docx

3922_1_3 Pemetrexed Mylan Pharma milt PCS PL 201112.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/3326/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Pemetreksedas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
60209	74482	1074482	flakonas	N1		Receptinis	LT/1/16/3922/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-08-27	Išregistruotas
2016-05-27	Registruotas